The TRIUMPH-4 Phase 3 trial in obesity with knee osteoarthritis later reported 28.7% mean weight loss at 68 weeks with retatrutide 12 mg/week, and identified a dose-related dysesthesia (nerve-tingling) signal in 8.8% of 9 mg and 20.9% of 12 mg patients (Bays et al., 2025)
The downsides of microdosing GLP-1s The main downside is that you likely wont see results quite as quickly as you would with a higher dose
See if You Qualify The Zepbound Blindness Lawsuit is an active lawsuit See If You Qualify Lawsuits are currently being filed against the manufacturer of Zepbound, alleging that the medication can cause vision problems such as vision loss, blurry vision, and blindness
It is to look at the full picture: triggers, inflammation, gut health, immune burden, nervous system stress, nutrient status, and the factors that may be making mast cells more unstable